Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1997
Report date:
1997

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
GLP compliance:
yes (incl. QA statement)
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Data was available before REACh was in place.

Test material

Constituent 1
Chemical structure
Reference substance name:
1-(4-chlorophenyl)pyrazol-3-ol
EC Number:
616-307-3
Cas Number:
76205-19-1
Molecular formula:
C9 H7 Cl N2 O
IUPAC Name:
1-(4-chlorophenyl)pyrazol-3-ol
Specific details on test material used for the study:
- Name of test material (as cited in study report): pyrazolon
- Physical state: crystalline powder, light-beige
- Analytical purity: 100.5 g/100 g (H-NMR and IR spectroscopy)
- Storage condition of test material: room temperature, exclusion of light

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River GmbH, Wiga, Kisslegg, Federal Republic of Germany
- Age at study initiation: young adults
- Weight at study initiation: 344 - 400 g
- Housing: 5/cage
- Diet (e.g. ad libitum): ad libitum (Kliba labor diet 341, assayed for chemical and microbiological contaminants)
- Water (e.g. ad libitum): ad libitum (tap water; about 2 g of ascorbic acid per 10l water was added to the drinking water twice a week, water is regularly assayed for chemical contaminants)
- Acclimation period: 7 days before the beginning of the study


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24°C (deviations that would have had an adverse effect on the test results did not occur)
- Humidity (%): 30 - 70% (deviations that would have had an adverse effect on the test results did not occur)
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
CMC (carboxymethyl cellulose)
Concentration / amount:
Vehicle: 1% CBC (Tylose CB 30000) in aqua bidest.

intradermal induction: 5% test substance preparation
percutaneous induction: 25% test substance preparation
1st and 2nd challenge: 10% test substance preparation
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
CMC (carboxymethyl cellulose)
Concentration / amount:
Vehicle: 1% CBC (Tylose CB 30000) in aqua bidest.

intradermal induction: 5% test substance preparation
percutaneous induction: 25% test substance preparation
1st and 2nd challenge: 10% test substance preparation
No. of animals per dose:
Control group 1: 5
Control group 2: 5 (second control group has been intended for a potential 2nd challenge in case of borderline results at the first challenge)
Test group: 10
Details on study design:
RANGE FINDING TESTS:
The concentrations of the test substance suitable for use in the main experiment were determined in the pretest.
The pretest was performed with 4 female animals for percutaneous and with 2 female animals for intradermal induction.

MAIN STUDY
A1. INDUCTION EXPOSURE - intradermal induction
- No. of exposures: 1
- Test groups:
A) front row : 2 injections each of 0 .1 ml Freund's adjuvant without test substance emulsified with 0 .9% aqueous NaCl-solution in a ratio of 1 : 1;
B) middle row : 2 injections each of 0 .1 ml of the test substance formulation;
C) back row : 2 injections each of 0 .1 ml Freund's adjuvant / 0 .9% aqueous NaCl-solution (1 : 1) with test substance
- Control group:
The animals were given the same injections (A, B, C) but without test substance, only with the formulating agent .
- Site: shoulder
- Frequency of applications: 1
- Concentrations: Test groups - 5% test substance preparations
- Readings: 24 h after the beginning of application, (scoring according to OECD 406)


A2. INDUCTION EXPOSURE - precutaneous induction
One week after intradermal induction
- No. of exposures: 1
- Test groups: 2 x 4 cm filter paper strips containing the test substance formulation were applied under an occlusive dressing
- Control group: 2 x 4 cm filter paper strips containing the solvent were applied under an occlusive dressing
- Site: shoulder, same area as in the case of the previous intradermal application
- Exposure time: 48 hours
- Frequency of applications: 1
- Concentrations: Test groups - 25% test substance preparations
- Readings: 48 hour after the beginning of application, (scoring according to OECD 406)

B. CHALLENGE EXPOSURE (1st and 2nd challenge)
- No. of exposures: 1
- Day(s) of challenge: 1st challenge - 14 days after the percutaneous induction; 2nd challenge - 21 days after the percutaneous induction (1 week after 1st challenge)
- Exposure period: 24 hours
- Test groups: 2 x 2 cm filter paper strips containing the test substance formulation were applied under an occlusive dressing
- Control group: 2 x 2 cm filter paper strips containing the test substance formulation were applied under an occlusive dressing
- Site: intact flank
- Concentrations: 10% test substance preparations
- Evaluation (hr after challenge): 24 and 48 h after the removal of the patch

1st challenge :
- The test group and control group 1 were treated with the test substance formulation . Additionally 1% solution of Tylose CB 30 .000 in aqua bidest .
was applied as a vehicle control to all animals . Control group 2 only received 1 % solution of Tylose CB 30 .000 in aqua bidest .
2nd challenge :
- The test group and control groups 1 and 2 were treated with the test substance formulation . Analogous to the lst challenge 1 % solution of
Tylose CB 30 .000 in aqua bidest . was applied as a vehicle control to all animals .

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
other: 1st reading, 1st challenge
Hours after challenge:
24
Group:
other: negative control 1
Dose level:
10%
No. with + reactions:
0
Total no. in group:
4
Remarks on result:
other: Reading: other: 1st reading, 1st challenge. . Hours after challenge: 24.0. Group: other: negative control 1. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 4.0.
Reading:
other: 2nd reading, 1st challenge
Hours after challenge:
48
Group:
other: negative control 1
Dose level:
10%
No. with + reactions:
0
Total no. in group:
4
Remarks on result:
other: Reading: other: 2nd reading, 1st challenge. . Hours after challenge: 48.0. Group: other: negative control 1. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 4.0.
Reading:
other: 1st reading, 1st challenge
Hours after challenge:
24
Group:
test chemical
Dose level:
10%
No. with + reactions:
3
Total no. in group:
10
Remarks on result:
other: Reading: other: 1st reading, 1st challenge. . Hours after challenge: 24.0. Group: test group. Dose level: 10%. No with. + reactions: 3.0. Total no. in groups: 10.0.
Reading:
other: 2nd reading, 2nd challenge
Hours after challenge:
48
Group:
test chemical
Dose level:
10%
No. with + reactions:
3
Total no. in group:
10
Remarks on result:
other: Reading: other: 2nd reading, 2nd challenge. . Hours after challenge: 48.0. Group: test group. Dose level: 10%. No with. + reactions: 3.0. Total no. in groups: 10.0.
Reading:
other: 1st reading, 2nd challenge
Hours after challenge:
24
Group:
other: negative control 2
Dose level:
10%
No. with + reactions:
0
Total no. in group:
4
Remarks on result:
other: Reading: other: 1st reading, 2nd challenge. . Hours after challenge: 24.0. Group: other: negative control 2. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 4.0.
Reading:
other: 2nd reading, 2nd challenge
Hours after challenge:
48
Group:
other: negative control 2
Dose level:
10%
No. with + reactions:
0
Total no. in group:
4
Remarks on result:
other: Reading: other: 2nd reading, 2nd challenge. . Hours after challenge: 48.0. Group: other: negative control 2. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 4.0.
Reading:
other: 1st reading, 2nd challenge
Hours after challenge:
24
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: other: 1st reading, 2nd challenge. . Hours after challenge: 24.0. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
other: 2nd reading, 2nd challenge
Hours after challenge:
48
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: other: 2nd reading, 2nd challenge. . Hours after challenge: 48.0. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 10.0.

Any other information on results incl. tables

Induction:

After the intradermal induction well-defined erythema and slight edema were observed at the injection sites of all control group animals and all test group animals at which only Freund's adjuvant/0 .9% aqueous NaCl-solution (1 : 1) was applied . Injections of 5% test substance preparations in Tylose CB 30 .000, 1% in aqua bidest . or in Freund's adjuvant/0 .9% aqueous NaCl-solution (1 : 1) caused well-defined erythema and slight edema in all test group animals . The injection sites of all control group animals at which Tylose CB 30 .000, 1% in aqua bidest . was applied, did not show any skin reactions .

After the percutaneous induction with a 25% test substance preparation incrustation, partially open (caused by the intradermal induction), could be observed in addition to well-defined erythema and slight edema in all test group animals . The animals of control groups 1 and 2, which were applied with Tylose CB 30 .000, 1% in aqua bidest ., exhibited the same skin reactions as the animals of the test group .

1st Challenge:

After the lst challenge 1 out of 10 test group animals showed very slight erythema 24 hours after removal of the patches . 2 test group animals exhibited well-defined erythema . 1 out of these animals additionally showed scaling and very slight edema . Very slight erythema were observed in 3 out of 10 test group animals 48 hours after removal of the patches . 2 out of these animals additionally showed scaling .

The animals of control group 1 did not show any skin reactions . Tylose CB 30 .000, 1% in aqua bidest ., which was applied as a vehicle control to all animals, did not cause any skin reactions .

2nd Challenge:

After the 2nd challenge with a 10% test substance preparation no skin reactions were observed in all animals of the test group and control groups 1 and 2 24 and 48 hours after removal of the patches .

Tylose CB 30 .000, 1% in aqua bidest, which was applied as a vehicle control to all animals, did not cause any skin reactions .

Table 1: Skin findings after the challenge

1st challenge

2nd challenge

Test substance

(10% in vehicle)

Vehicle

Test substance

(10% in vehicle)

Vehicle

Control

group 1

0/4*

0/4*

0/4*

0/4*

Control

group 2

No application of test substance

0/4*

0/4*

0/4*

Test group

3/10*

0/10*

0/10*

0/10*

* number of positive reactions/number of animals tested (reading at 24h and/or at 48 hours after removal of the patch)

Body weights:

The expected body weight gain was generally observed in the course of the study .

Mortality:

1 animal of control group 1 and 1 animal of control group 2 died 10 days after the beginning of the study . Macroscopic examination revealed that the animals suffered from pneumonia . The cause of death was not related to the test substance treatment .

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met